These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28862172)

  • 1. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccines against viral hepatitis B: results and prospects].
    Mukomolov SL
    Tr Inst Im Pastera; 1992; 67():103-15. PubMed ID: 8539762
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
    Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
    Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
    [No Abstract]   [Full Text] [Related]  

  • 4. The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.
    Emir S; Büyükpamuk M; Akyüz C; Kutluk T; Güler E; Cağlar K
    Pediatr Hematol Oncol; 2002 Jun; 19(4):227-33. PubMed ID: 12051588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.
    Joung YH; Park SH; Moon KB; Jeon JH; Cho HS; Kim HS
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine recombinant (Janssen/Medeva). Hepagene.
    Drugs R D; 1999 Sep; 2(3):201-2. PubMed ID: 10641227
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B vaccine recombinant (bio-technology general). BioHepB, Sci-B-Vac.
    Drugs R D; 1999 Sep; 2(3):199-200. PubMed ID: 10641226
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonresponders to hepatitis B vaccine.
    Jenson HB
    Postgrad Med; 2000 Mar; 107(3):97-8. PubMed ID: 10728138
    [No Abstract]   [Full Text] [Related]  

  • 9. Success of mass vaccination of infants against hepatitis B.
    Durand AM; Sabino H; Mahoney F
    JAMA; 1996 Dec; 276(22):1802-3. PubMed ID: 8946897
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M; Jones CD; Bailey C
    Intervirology; 2001; 44(2-3):88-97. PubMed ID: 11509870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population.
    Jacques P; Moens G; Desombere I; Dewijngaert J; Leroux-Roels G; Wettendorff M; Thoelen S
    Vaccine; 2002 Nov; 20(31-32):3644-9. PubMed ID: 12399191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B vaccine].
    Kurokohchi K; Kuriyama S
    Nihon Rinsho; 2005 May; 63 Suppl 5():638-42. PubMed ID: 15954422
    [No Abstract]   [Full Text] [Related]  

  • 13. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
    Marinho RT; Ramalho F; Velosa J
    Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
    Gerlich WH; Glebe D
    EBioMedicine; 2016 Sep; 11():5-6. PubMed ID: 27485030
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HBs antigenemia and vaccination against hepatitis B virus: attention to chronology of markers].
    Beaulieu S; Lopez Y; Eugène C
    Presse Med; 2000 Oct; 29(32):1762-3. PubMed ID: 11098272
    [No Abstract]   [Full Text] [Related]  

  • 17. The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection.
    Gregorek H; Madaliński K; Woynarowski M; Mikołajewicz J; Syczewska M; Socha J
    Vaccine; 2000 Jan; 18(13):1210-7. PubMed ID: 10649622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Russian recombinant vaccine against hepatitis B (results of controlled trials)].
    Pavlova LI; Gorbunov MA; Borisova VN; Krasil'nikov IV; Noskova AV; Lytsar' BN; Skvortsov SV; Beliakova EA; Iakovleva IM; Korovin IuP; Bel'chenko AV; Titov IA; Budanov MV
    Vopr Virusol; 1996; 41(4):170-2. PubMed ID: 8999672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccination among the Nicobarese tribe: Need to document the impact.
    Murhekar M
    Indian J Med Res; 2015 May; 141(5):662. PubMed ID: 26139786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.